AAAylin Albrecht

Aylin Albrecht

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Aylin Albrecht has a total of 18 co-authors. Here are the top co-authors by number of shared publications:

  • Lorenz Kapral

    Department of Anaesthesia, Intensive Care Medicine and Pain Medicine, Clinical Division of General Anaesthesia and Intensive Care Medicine, Medical University of Vienna, Vienna, Austria

    4 shared publications
  • Oliver Kimberger

    Clinical Division of General Anaesthesia and Intensive Care Medicine, Department of Anaesthesia, Intensive Care Medicine and Pain Medicine, Medical University of Vienna, 1090 Vienna, Austria

    4 shared publications
  • Felix Gruber

    Federation of Social Insurance Vienna Austria

    2 shared publications
  • Andrea Michalek-Sauberer

    Department of Anaesthesia, Intensive Care Medicine and Pain Medicine, Division of Special Anaesthesia and Pain Therapy, Medical University of Vienna, Vienna, Austria

    1 shared publication
  • Christian Albrecht

    First Orthopaedic Department, Orthopedic Hospital Speising, Vienna, Austria

    1 shared publication
  • Christoph Dibiasi

    Medical University of Vienna, Department of Anaesthesia, Intensive Care Medicine and Pain Medicine, Währinger Gürtel 18-20, Vienna 1090, Austria

    1 shared publication

Latest Publications

  • Open Access

    Short-Term Prediction of Severe Anemia in Critically Ill Patients Using Machine Learning: Development and External Validation

    by Lorenz Kapral, Aylin Albrecht, Fabian P. Hammerle, Stefan Bartos, Paul Lichtenegger, Sebastian Zeiner, Stefan J. Schaller, Oliver Kimberger, David M. Baron

    Background: Severe anaemia is common in critically ill patients, frequently necessitating urgent diagnostic evaluation, haemodynamic reassessment, and red-blood-cell transfusion. Current ICU practice heavily relies on intermittent haemoglobin (Hb) measurements, which inherently delay recognition of clinically relevant Hb decline. We aimed to develop and externally validate a machine-learning model to predict severe anaemia (Hb <8 g/dL) within the next 6 hours using only routinely collected ICU data.Methods; In this retrospective observational cohort study, we developed an Extreme Gradient Boosting model using the Vienna Anaesthesia and Intensive Care Database (ViennaAIdb; Medical University of Vienna, Austria) for ICU admissions between Jan 1, 2014, and Nov 30, 2021. The primary outcome was severe anaemia within a 6-hour prediction horizon. The cohort was split at the patient level into training and internal test sets. External validation was performed using the MIMIC-IV database (v3.1) via an identical preprocessing pipeline and entirely without model retraining. Model performance was assessed by discrimination, using the area under the receiver operating characteristic curve (AUC), and calibration, using calibration plots and Brier scores. Feature contributions were evaluated with SHapley Additive exPlanations.Findings: The development cohort included 21,731 ICU stays, contributing 3,321,230 hourly prediction samples; the external validation cohort included 821 ICU stays, contributing 11,217 samples. The model demonstrated high discrimination in both cohorts, with an AUC of 0·94 in internal testing and 0·91 in external validation. Calibration was excellent internally and remained robust externally, with close agreement between predicted and observed risks (Brier scores of 0·055 and 0·110, respectively). The most influential predictors of impending anaemia were recent Hb dynamics, cumulative urine output, heart rate, and fluid administration.Interpretation: A machine-learning model based exclusively on routinely available ICU variables accurately predicted severe anaemia within a clinically actionable 6-hour horizon, demonstrating robust discrimination and calibration during external validation without retraining. These findings suggest that automated, near real-time Hb risk stratification could support a shift from reactive laboratory surveillance towards anticipatory monitoring and earlier bedside reassessment. Prospective evaluation is warranted before clinical implementation.FundingNo specific funding was received.

  • Open Access

    Prophylactic Enoxaparin Reduces Symptomatic Venous Thromboembolism Compared With No Chemoprophylaxis Within 95 Days After Knee Arthroscopy

    by Aylin Albrecht, Lorenz Kapral, Felix Gruber, Christoph Dibiasi, Oliver Kimberger, Christian Albrecht

    Purpose: To investigate whether prophylactic use of low‐molecular‐weight heparin (enoxaparin) after knee arthroscopy reduces the incidence of symptomatic venous thromboembolism (VTE) compared with no postoperative pharmacological prophylaxis. Methods: We conducted a population‐based cohort study using linked national insurance and hospital data from January 1, 2016, to December 31, 2023. Adults undergoing standard knee arthroscopy were identified and included, and those with prior VTE, coagulation disorders, recent cancer, preoperative anticoagulation, septic arthritis, or extended hospital stay were excluded. Patients filling a prophylactic enoxaparin prescription within 5 days of discharge comprised the enoxaparin group; all others formed the control group. The primary outcome was symptomatic VTE (combined deep vein thrombosis and pulmonary embolism) within 90 days after group allocation. Secondary safety outcomes included wound infection, septic arthritis, heparin‐induced thrombocytopenia, intracranial hemorrhage, gastrointestinal bleeding, epistaxis, and surgery‐related bleeding leading to hospitalization. Results: Of 181,135 knee arthroscopies identified, 99,916 patients met the inclusion criteria. Among them, 67,108 (67%) received enoxaparin and 32,808 (33%) did not. Symptomatic VTE occurred in 380 patients (0.57%) in the enoxaparin group and 293 patients (0.89%) in the control group. Enoxaparin prophylaxis was associated with a significantly lower incidence of symptomatic VTE (hazard ratio: 0.64; 95% confidence interval: 0.55‐0.74; P = .0003), corresponding to a number needed to treat of 310 to prevent 1 symptomatic event. Adverse events were rare in both groups. Conclusions: Prophylactic enoxaparin after knee arthroscopy was associated with a significantly reduced risk of symptomatic VTE within 95 days of discharge compared with no pharmacological prophylaxis. Level of Evidence: Level III, retrospective comparative case series.

  • Open Access

    Trends in Opioid and Non-opioid Prescriptions in Austria (2016–2021): A Nationwide Study on Utilization and Concomitant Benzodiazepine Use

    by Aylin Bilir, Lorenz Kapral, Andrea Michalek-Sauberer, Razvan Bologheanu, Felix Gruber, Oliver Kimberger

    Introduction Although global opioid consumption is decreasing, high-income populations are experiencing an increase. Data on specific opioid-prescribed and at-risk patient groups in Austria are lacking. Methods We performed a retrospective observational population-based study analysing health insurance data between January 2016 and December 2021. The dataset included demographic information; hospital data, including coded primary and secondary discharge diagnoses; and prescription data for all legally available opioids and nonopioid analgesics. The primary objective was to describe trends in opioid and nonopioid analgesic prescriptions. Logistic regression analysis was conducted to identify potential risk factors for receiving an opioid prescription. Results The study cohort included 7,274,651 individuals. During the observation period, the percentage of individuals receiving an opioid prescription decreased by 14.69% (4.22–3.60%). The number of individuals receiving an opioid prescription was consistently greatest for tramadol. A particularly strong positive correlation was observed between opioid prescriptions and the concurrent use of benzodiazepines (odds ratio [OR], 1.45 [95% confidence interval {CI}, 1.43–1.47]). Furthermore, a history of persistent somatoform pain disorder (OR, 1.28 [95% CI, 1.21–1.36]) and a diagnosis of pain disorder (OR, 1.26 [95% CI, 1.25–1.28]) were identified as significant risk factors. In 2021, general practitioners were the predominant initial opioid prescribers, issuing 82.17% of the prescriptions, followed by hospital staff and orthopaedic specialists. Conclusion Prescription opioid use decreased from 2016 to 2021, with tramadol representing the most prevalent opioid. The study revealed a strong link between opioid and benzodiazepine prescriptions and an association with persistent somatoform pain disorder, where opioid use is typically not recommended. Interactive map available for this article.

  • Open Access

    Development and external validation of temporal fusion transformer models for continuous intraoperative blood pressure forecasting

    by Lorenz Kapral, Christoph Dibiasi, Natasa Jeremic, Stefan Bartos, Sybille Behrens, Aylin Bilir, Clemens Heitzinger, Oliver Kimberger